Definition of transcriptome‑based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP‑Toxukn and STOP‑Toxukk tests May 2, 2022 | 2016, Archives of Toxicology, Publication - legacy work ‹ Previous In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities Next › Astrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder Research
